Global Lupus Community Rallied by Lady Gaga, Selena Gomez, Norm Lewis and a Host of Inspiring Lupus Advocates New York, NY. November 24, 2020 – The Lupus Research Alliance (LRA)’s 2020 Virtual Fundraising Event surpassed its goal last night, raising $3.1 million for lupus research programs. Led by inspiring words from Lady Gaga and Selena Gomez […] READ MORE
November 19, 2020 Lady Gaga and Selena Gomez Invite Global Lupus Community New York, NY. November 19 – The Lupus Research Alliance (LRA) is taking the show on-line this year with a preeminent virtual Fundraising Event celebrating extraordinary scientific achievements. Performances will include a special tribute by the one-and-only Lady Gaga and a solo by Broadway […] READ MORE
30+ presentations of studies funded by the Lupus Research Alliance on a variety of immune pathways Results from three clinical studies conducted in part by LRA-affiliate Lupus Therapeutics (LT) through its trials network 10 lupus presentations by the Accelerating Medicines Partnership Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE) program (AMP RA/SLE) NEW YORK, NY, […] READ MORE
NEW YORK, NY, November 9, 2020. The Lupus Research Alliance proudly announced today the 2020 Lupus Innovation Award recipients. These seven projects represent a wide breadth of scientific exploration in lupus, probing the development and progression of lupus while pointing to potential treatment approaches. The Lupus Innovation Award offers up to $150,000/year total costs for […] READ MORE
New York, NY. September 25 — The Lupus Research Alliance presented its 2020 Lupus Insight Prize to Jane Salmon, MD for her work in improving the health of pregnant women with lupus and antiphospholipid syndrome. The prize was formally “presented” to Dr. Salmon by LRA Scientific Advisory Board Chair Gary Koretzky, MD during a virtual […] READ MORE
September 16, 2020 NEW YORK, NY. The Lupus Research Alliance welcomes positive BLISS-LN Phase 3 data published in this week’s New England Journal of Medicine, demonstrating that GSK’s drug Benlysta® (belimumab) significantly improved kidney function in adults with lupus nephritis, the most common severe complication of lupus causing inflammation and serious damage to the kidney. The […] READ MORE
NEW YORK, NY. July 22. The Lupus Research Alliance congratulates Aurinia Pharmaceuticals Inc. on acceptance of its NDA filing and priority review designation by the U.S. Food and Drug Administration for its investigational drug voclosporin for lupus nephritis. A serious inflammation of the kidneys, lupus nephritis is one of the most common complications of systemic […] READ MORE
NEW YORK, NY. July 14, 2020 — The Lupus Research Alliance (LRA) is pleased to announce the recipients of the inaugural LRA-BMS Accelerator Award*, a collaborative project with sponsoring partner Bristol Myers Squibb. The Award provides a collective total of $3,000,000 to support ten cutting-edge lupus research projects over two years that focus on […] READ MORE
NEW YORK, NY, May 28. More than one third of people with lupus experienced significant issues filling their hydroxychloroquine (Plaquenil) prescriptions during the COVID-19 pandemic, according to results of a new survey conducted by the Lupus Research Alliance (LRA). Hydroxychloroquine shortages in March and April coincided with early data broadly reported in the media suggesting […] READ MORE
New York, NY, April 7, 2020 – Lupus Therapeutics, the clinical trial affiliate of the Lupus Research Alliance (LRA), announced today that it is embarking on a clinical study to assess the potential benefit of hydroxychloroquine and/or other lupus therapies in preventing or reducing the symptoms of COVID-19 in people with lupus. The study […] READ MORE
March 26, 2020 The Lupus Research Alliance (LRA), the world’s leading research organization dedicated to lupus research, continues to watch rapidly changing developments regarding COVID-19 and is closely monitoring the policies and actions of the federal government, healthcare agencies, medical organizations and the pharmaceutical industry on behalf of people with lupus. Thrust into the spotlight […] READ MORE
December 17, 2019 The Lupus Research Alliance is thrilled to share exciting news from GSK that Benlysta (belimumab) demonstrated positive clinical trial results in treating lupus nephritis (LN), a common complication of lupus causing inflammation of the kidneys that can result in end-stage kidney disease. Called BLISS-LN, this Phase 3 trial is the largest one […] READ MORE
